Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System

NCT02097082 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease
Intermittent Claudication
Vascular Diseases
Cardiovascular Diseases

Interventions

DEVICE: STANZA Drug-eluting resorbable Scaffold

Sponsor

480 Biomedical